Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Placenta Accreta | 16 | 2023 | 237 | 4.130 |
Why?
|
Placenta | 30 | 2024 | 1709 | 3.980 |
Why?
|
Endometrial Neoplasms | 23 | 2021 | 1366 | 3.350 |
Why?
|
Carcinoma, Endometrioid | 11 | 2020 | 276 | 1.860 |
Why?
|
Adenocarcinoma, Clear Cell | 11 | 2019 | 217 | 1.610 |
Why?
|
Ovarian Neoplasms | 33 | 2024 | 4876 | 1.580 |
Why?
|
Endometrial Hyperplasia | 5 | 2021 | 97 | 1.410 |
Why?
|
Placentation | 2 | 2020 | 78 | 1.240 |
Why?
|
Fallopian Tube Neoplasms | 5 | 2020 | 328 | 1.210 |
Why?
|
Postpartum Hemorrhage | 4 | 2024 | 271 | 1.160 |
Why?
|
Precancerous Conditions | 7 | 2020 | 980 | 1.110 |
Why?
|
Cystadenocarcinoma, Serous | 7 | 2022 | 478 | 1.100 |
Why?
|
Carcinoma in Situ | 4 | 2020 | 791 | 1.070 |
Why?
|
Hysterectomy | 7 | 2022 | 857 | 1.050 |
Why?
|
Chorioamnionitis | 7 | 2020 | 156 | 1.030 |
Why?
|
Endometrium | 6 | 2021 | 403 | 0.980 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 3 | 2017 | 558 | 0.980 |
Why?
|
Placenta Diseases | 7 | 2024 | 199 | 0.960 |
Why?
|
Adnexal Diseases | 6 | 2019 | 104 | 0.960 |
Why?
|
Placenta Previa | 5 | 2023 | 122 | 0.890 |
Why?
|
Pregnancy | 58 | 2024 | 29874 | 0.830 |
Why?
|
Autopsy | 3 | 2021 | 1008 | 0.770 |
Why?
|
Prenatal Diagnosis | 5 | 2024 | 1265 | 0.750 |
Why?
|
Teratoma | 1 | 2024 | 404 | 0.740 |
Why?
|
Mycobacterium bovis | 1 | 2021 | 147 | 0.730 |
Why?
|
Cysts | 3 | 2021 | 681 | 0.710 |
Why?
|
Placental Insufficiency | 2 | 2017 | 50 | 0.670 |
Why?
|
Fetal Growth Retardation | 6 | 2016 | 580 | 0.660 |
Why?
|
Pathology, Clinical | 2 | 2020 | 376 | 0.610 |
Why?
|
Cervix Uteri | 5 | 2021 | 570 | 0.590 |
Why?
|
Carcinoma | 5 | 2022 | 2330 | 0.590 |
Why?
|
Cesarean Section | 9 | 2023 | 1396 | 0.590 |
Why?
|
Female | 158 | 2024 | 392644 | 0.580 |
Why?
|
Adenocarcinoma | 10 | 2013 | 6346 | 0.570 |
Why?
|
Pre-Eclampsia | 6 | 2017 | 1231 | 0.560 |
Why?
|
Eclampsia | 1 | 2017 | 56 | 0.560 |
Why?
|
Decidua | 1 | 2016 | 82 | 0.520 |
Why?
|
Pregnancy Trimester, Second | 6 | 2024 | 731 | 0.490 |
Why?
|
Infant, Small for Gestational Age | 2 | 2017 | 461 | 0.480 |
Why?
|
Endometritis | 2 | 2021 | 49 | 0.470 |
Why?
|
Obstetric Labor, Premature | 6 | 2014 | 272 | 0.470 |
Why?
|
Medical Records | 1 | 2020 | 1408 | 0.470 |
Why?
|
Uterus | 2 | 2021 | 649 | 0.470 |
Why?
|
Gestational Age | 16 | 2021 | 3577 | 0.450 |
Why?
|
Infant, Premature | 12 | 2022 | 2107 | 0.450 |
Why?
|
Endometriosis | 2 | 2021 | 870 | 0.440 |
Why?
|
Tissue Array Analysis | 4 | 2016 | 550 | 0.430 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2021 | 384 | 0.430 |
Why?
|
Humans | 182 | 2024 | 761504 | 0.430 |
Why?
|
Uterine Neoplasms | 3 | 2020 | 1420 | 0.430 |
Why?
|
Premature Birth | 5 | 2022 | 1782 | 0.420 |
Why?
|
Umbilical Cord | 3 | 2011 | 177 | 0.420 |
Why?
|
Terminology as Topic | 1 | 2020 | 1530 | 0.420 |
Why?
|
Lymph Nodes | 4 | 2019 | 3466 | 0.410 |
Why?
|
Ultrasonography, Prenatal | 8 | 2024 | 1755 | 0.410 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1496 | 0.400 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2014 | 311 | 0.400 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2011 | 13 | 0.390 |
Why?
|
Vascular Diseases | 2 | 2020 | 1161 | 0.390 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2016 | 380 | 0.390 |
Why?
|
Receptors, Progesterone | 3 | 2016 | 1129 | 0.360 |
Why?
|
Amniotic Fluid | 2 | 2011 | 378 | 0.360 |
Why?
|
Down-Regulation | 2 | 2017 | 2919 | 0.360 |
Why?
|
Ovarian Cysts | 3 | 2021 | 108 | 0.350 |
Why?
|
Immunohistochemistry | 17 | 2023 | 11076 | 0.350 |
Why?
|
Estrogen Receptor alpha | 2 | 2016 | 582 | 0.340 |
Why?
|
Lymph Node Excision | 3 | 2019 | 1271 | 0.330 |
Why?
|
Blood Proteins | 3 | 2016 | 1173 | 0.330 |
Why?
|
Mesothelioma | 3 | 2006 | 807 | 0.330 |
Why?
|
Kidney | 3 | 2021 | 7048 | 0.320 |
Why?
|
Integrin alphaV | 1 | 2008 | 54 | 0.320 |
Why?
|
Fallopian Tubes | 3 | 2020 | 177 | 0.310 |
Why?
|
Integrin beta Chains | 1 | 2008 | 115 | 0.310 |
Why?
|
Up-Regulation | 2 | 2017 | 4124 | 0.310 |
Why?
|
Tuberculosis | 1 | 2021 | 2017 | 0.310 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 2007 | 5 | 0.300 |
Why?
|
Observer Variation | 6 | 2019 | 2606 | 0.300 |
Why?
|
Biopsy | 8 | 2021 | 6766 | 0.300 |
Why?
|
Middle Aged | 61 | 2024 | 220895 | 0.300 |
Why?
|
Adult | 63 | 2024 | 221177 | 0.290 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2021 | 2020 | 0.280 |
Why?
|
Pregnancy, Ectopic | 2 | 2024 | 142 | 0.280 |
Why?
|
Infant, Newborn | 23 | 2023 | 26198 | 0.270 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1181 | 0.270 |
Why?
|
Ovary | 3 | 2013 | 959 | 0.260 |
Why?
|
Fetal Heart | 1 | 2007 | 281 | 0.260 |
Why?
|
Diagnostic Errors | 3 | 2009 | 1265 | 0.260 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 428 | 0.250 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2645 | 0.250 |
Why?
|
Diseases in Twins | 1 | 2007 | 446 | 0.250 |
Why?
|
Liver | 2 | 2021 | 7529 | 0.250 |
Why?
|
Epididymal Secretory Proteins | 1 | 2005 | 12 | 0.250 |
Why?
|
Parity | 3 | 2017 | 927 | 0.250 |
Why?
|
Fetal Diseases | 2 | 2007 | 913 | 0.250 |
Why?
|
Case-Control Studies | 18 | 2023 | 22176 | 0.250 |
Why?
|
Uterine Hemorrhage | 1 | 2006 | 240 | 0.250 |
Why?
|
beta Catenin | 2 | 2020 | 1040 | 0.240 |
Why?
|
Menstruation | 1 | 2006 | 307 | 0.240 |
Why?
|
WT1 Proteins | 2 | 2002 | 184 | 0.240 |
Why?
|
Down Syndrome | 5 | 2016 | 901 | 0.230 |
Why?
|
Cell Adhesion Molecules | 5 | 2011 | 1600 | 0.230 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2011 | 2151 | 0.230 |
Why?
|
Chorion | 2 | 2018 | 114 | 0.230 |
Why?
|
Mucin-1 | 3 | 2021 | 540 | 0.220 |
Why?
|
Transcription Factors | 8 | 2024 | 12128 | 0.220 |
Why?
|
Biopsy, Needle | 3 | 2003 | 1626 | 0.220 |
Why?
|
Facies | 1 | 2024 | 222 | 0.220 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.220 |
Why?
|
Neural Stem Cells | 4 | 2018 | 888 | 0.210 |
Why?
|
Fetoscopy | 1 | 2024 | 133 | 0.210 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 12974 | 0.200 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 321 | 0.200 |
Why?
|
Complement Activation | 2 | 2021 | 445 | 0.200 |
Why?
|
Polyps | 1 | 2004 | 200 | 0.200 |
Why?
|
Hydrops Fetalis | 1 | 2022 | 113 | 0.200 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 412 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2006 | 2825 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2013 | 487 | 0.200 |
Why?
|
Hydatidiform Mole | 1 | 2024 | 255 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 318 | 0.200 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2024 | 258 | 0.200 |
Why?
|
Pregnancy Proteins | 2 | 2014 | 222 | 0.200 |
Why?
|
Fibroma | 1 | 2023 | 190 | 0.190 |
Why?
|
Cystadenoma | 1 | 2021 | 79 | 0.190 |
Why?
|
Cystadenoma, Mucinous | 1 | 2021 | 62 | 0.190 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 2011 | 137 | 0.190 |
Why?
|
Curettage | 2 | 2021 | 74 | 0.190 |
Why?
|
Immunoenzyme Techniques | 5 | 2009 | 1705 | 0.190 |
Why?
|
Myiasis | 1 | 2001 | 14 | 0.190 |
Why?
|
Skin Diseases, Parasitic | 1 | 2001 | 13 | 0.190 |
Why?
|
Aged | 35 | 2024 | 169289 | 0.190 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3201 | 0.190 |
Why?
|
Lymphatic Metastasis | 5 | 2013 | 2915 | 0.190 |
Why?
|
Translocation, Genetic | 2 | 2024 | 1393 | 0.190 |
Why?
|
Stromal Cells | 1 | 2006 | 1330 | 0.190 |
Why?
|
Cerebral Palsy | 2 | 2020 | 474 | 0.190 |
Why?
|
Diptera | 1 | 2001 | 50 | 0.180 |
Why?
|
Cerebral Cortex | 5 | 2018 | 5777 | 0.180 |
Why?
|
Complement Pathway, Alternative | 1 | 2021 | 113 | 0.180 |
Why?
|
Internet | 2 | 2011 | 3092 | 0.180 |
Why?
|
PAX2 Transcription Factor | 1 | 2020 | 86 | 0.180 |
Why?
|
Fetus | 3 | 2018 | 1863 | 0.180 |
Why?
|
Aged, 80 and over | 16 | 2021 | 58976 | 0.180 |
Why?
|
Nuclear Proteins | 4 | 2019 | 5796 | 0.180 |
Why?
|
Abortion, Spontaneous | 2 | 2024 | 533 | 0.170 |
Why?
|
Matrix Metalloproteinases | 3 | 2011 | 393 | 0.170 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3595 | 0.170 |
Why?
|
Logistic Models | 7 | 2016 | 13255 | 0.170 |
Why?
|
Postmenopause | 4 | 2021 | 2513 | 0.170 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 168 | 0.170 |
Why?
|
Forms and Records Control | 1 | 2020 | 158 | 0.170 |
Why?
|
Endosonography | 1 | 2003 | 609 | 0.170 |
Why?
|
Obstetrics | 2 | 2023 | 665 | 0.160 |
Why?
|
Microsatellite Instability | 3 | 2020 | 716 | 0.160 |
Why?
|
Endodermal Sinus Tumor | 1 | 2019 | 53 | 0.160 |
Why?
|
S100 Proteins | 2 | 2011 | 218 | 0.160 |
Why?
|
Genital Neoplasms, Female | 2 | 2018 | 532 | 0.160 |
Why?
|
Birth Weight | 1 | 2007 | 2103 | 0.160 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 97 | 0.160 |
Why?
|
DNA Polymerase II | 1 | 2019 | 104 | 0.160 |
Why?
|
Reproducibility of Results | 7 | 2021 | 20098 | 0.160 |
Why?
|
BCG Vaccine | 1 | 2021 | 369 | 0.150 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 531 | 0.150 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 748 | 0.150 |
Why?
|
Abortion, Induced | 1 | 2024 | 462 | 0.150 |
Why?
|
Sarcoma | 2 | 2020 | 1801 | 0.150 |
Why?
|
Neurons | 8 | 2018 | 9463 | 0.150 |
Why?
|
Chemokines | 3 | 2011 | 960 | 0.150 |
Why?
|
Burkitt Lymphoma | 1 | 2000 | 335 | 0.150 |
Why?
|
Complement System Proteins | 1 | 2021 | 736 | 0.150 |
Why?
|
Reproductive History | 2 | 2016 | 211 | 0.150 |
Why?
|
Adrenergic beta-Agonists | 1 | 1999 | 345 | 0.150 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11121 | 0.150 |
Why?
|
Pregnancy, Multiple | 2 | 2010 | 215 | 0.150 |
Why?
|
Infant, Premature, Diseases | 3 | 2014 | 710 | 0.150 |
Why?
|
Nutrition Assessment | 1 | 2021 | 728 | 0.150 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2017 | 44 | 0.150 |
Why?
|
Fibromatosis, Aggressive | 1 | 2019 | 126 | 0.150 |
Why?
|
Bronchial Fistula | 1 | 2018 | 83 | 0.140 |
Why?
|
Chromosomes, Human, Pair 21 | 2 | 2016 | 228 | 0.140 |
Why?
|
Amnion | 1 | 2018 | 197 | 0.140 |
Why?
|
Chorionic Villi | 1 | 2017 | 53 | 0.140 |
Why?
|
Retrospective Studies | 19 | 2023 | 80636 | 0.140 |
Why?
|
Stress Fibers | 1 | 2017 | 55 | 0.140 |
Why?
|
Gastric Fistula | 1 | 2018 | 73 | 0.140 |
Why?
|
Triage | 1 | 2024 | 986 | 0.140 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2012 | 83 | 0.140 |
Why?
|
Language Development | 1 | 2018 | 183 | 0.140 |
Why?
|
Neoplasm Metastasis | 3 | 2004 | 4915 | 0.140 |
Why?
|
Vitamin B 6 | 2 | 2010 | 234 | 0.140 |
Why?
|
Septal Occluder Device | 1 | 2018 | 125 | 0.140 |
Why?
|
Immunocompromised Host | 1 | 2002 | 856 | 0.140 |
Why?
|
Abnormalities, Multiple | 1 | 2024 | 1423 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 698 | 0.140 |
Why?
|
Fetal Death | 1 | 2018 | 435 | 0.140 |
Why?
|
Bacteria | 1 | 2008 | 2199 | 0.140 |
Why?
|
RNA, Viral | 2 | 2021 | 2846 | 0.140 |
Why?
|
Hemoptysis | 1 | 2018 | 152 | 0.140 |
Why?
|
Nerve Growth Factors | 2 | 2011 | 564 | 0.140 |
Why?
|
Sodium Channels | 1 | 2018 | 339 | 0.140 |
Why?
|
Antigens, CD | 3 | 2016 | 4003 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3164 | 0.140 |
Why?
|
Tissue and Organ Procurement | 1 | 2005 | 961 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1993 | 0.130 |
Why?
|
Vagina | 1 | 2002 | 838 | 0.130 |
Why?
|
Gastroscopy | 1 | 2018 | 211 | 0.130 |
Why?
|
Desmin | 1 | 2016 | 99 | 0.130 |
Why?
|
Lung Injury | 1 | 2021 | 422 | 0.130 |
Why?
|
Hepatocytes | 1 | 2023 | 1233 | 0.130 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 236 | 0.130 |
Why?
|
Microcephaly | 2 | 2010 | 425 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 561 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 597 | 0.130 |
Why?
|
Chondrocytes | 3 | 2017 | 795 | 0.130 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15266 | 0.130 |
Why?
|
Nerve Tissue Proteins | 3 | 2015 | 4414 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 234 | 0.130 |
Why?
|
False Positive Reactions | 2 | 2012 | 957 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 612 | 0.130 |
Why?
|
Methionine | 2 | 2010 | 572 | 0.130 |
Why?
|
Rotator Cuff | 1 | 2019 | 348 | 0.130 |
Why?
|
Kidney Neoplasms | 3 | 2024 | 4249 | 0.130 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2016 | 144 | 0.130 |
Why?
|
MicroRNAs | 2 | 2022 | 3816 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2016 | 215 | 0.120 |
Why?
|
Gynecology | 3 | 2021 | 526 | 0.120 |
Why?
|
Cytokines | 5 | 2020 | 7396 | 0.120 |
Why?
|
Endemic Diseases | 2 | 2013 | 190 | 0.120 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 283 | 0.120 |
Why?
|
Uterine Cervical Diseases | 1 | 1995 | 73 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.120 |
Why?
|
Estrogens | 3 | 2023 | 1522 | 0.120 |
Why?
|
Health Maintenance Organizations | 1 | 1997 | 659 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1567 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 194 | 0.120 |
Why?
|
Anti-Asthmatic Agents | 1 | 1999 | 574 | 0.120 |
Why?
|
Repressor Proteins | 4 | 2020 | 2986 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 415 | 0.110 |
Why?
|
Pregnancy Outcome | 5 | 2018 | 2921 | 0.110 |
Why?
|
Ultrasonography | 4 | 2019 | 5972 | 0.110 |
Why?
|
Myocardium | 2 | 2021 | 4726 | 0.110 |
Why?
|
DNA Helicases | 1 | 2019 | 851 | 0.110 |
Why?
|
Antigens, CD34 | 1 | 2016 | 658 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2803 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 897 | 0.110 |
Why?
|
Risk Factors | 19 | 2023 | 74206 | 0.110 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 709 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1159 | 0.110 |
Why?
|
Fibrin | 1 | 2016 | 507 | 0.110 |
Why?
|
Oncogene Proteins, Viral | 1 | 1995 | 340 | 0.110 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2013 | 72 | 0.110 |
Why?
|
CDC2 Protein Kinase | 1 | 2014 | 213 | 0.110 |
Why?
|
Proportional Hazards Models | 7 | 2021 | 12463 | 0.110 |
Why?
|
Racemases and Epimerases | 1 | 2013 | 114 | 0.100 |
Why?
|
Chickenpox | 1 | 2013 | 96 | 0.100 |
Why?
|
Myometrium | 1 | 2013 | 174 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Organ Size | 2 | 2008 | 2254 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2767 | 0.100 |
Why?
|
Pregnancy Complications | 3 | 2012 | 2947 | 0.100 |
Why?
|
Clinical Competence | 1 | 2008 | 4792 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8547 | 0.100 |
Why?
|
Mass Vaccination | 1 | 2013 | 109 | 0.100 |
Why?
|
Bronchoscopy | 1 | 2018 | 909 | 0.100 |
Why?
|
Stem Cells | 3 | 2011 | 3522 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3133 | 0.100 |
Why?
|
Brain | 2 | 2018 | 27112 | 0.090 |
Why?
|
Folic Acid | 2 | 2010 | 1323 | 0.090 |
Why?
|
Stathmin | 1 | 2011 | 70 | 0.090 |
Why?
|
Peroxidase | 2 | 2011 | 609 | 0.090 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14666 | 0.090 |
Why?
|
Lung | 4 | 2021 | 10000 | 0.090 |
Why?
|
Parvovirus B19, Human | 1 | 2010 | 40 | 0.090 |
Why?
|
Telepathology | 1 | 2011 | 77 | 0.090 |
Why?
|
Prospective Studies | 13 | 2023 | 54425 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2014 | 992 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2011 | 664 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3123 | 0.090 |
Why?
|
Papillomaviridae | 2 | 2004 | 1119 | 0.090 |
Why?
|
Smoking | 5 | 2015 | 9053 | 0.090 |
Why?
|
Germ-Line Mutation | 2 | 2019 | 1858 | 0.090 |
Why?
|
Diplopia | 1 | 2011 | 214 | 0.090 |
Why?
|
Male | 36 | 2024 | 360804 | 0.090 |
Why?
|
Phenotype | 8 | 2022 | 16591 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2015 | 1136 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 1999 | 1809 | 0.080 |
Why?
|
Child Behavior Disorders | 1 | 2014 | 804 | 0.080 |
Why?
|
Twins, Monozygotic | 2 | 2010 | 470 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.080 |
Why?
|
Vasculitis | 2 | 2018 | 521 | 0.080 |
Why?
|
Ureaplasma urealyticum | 1 | 2009 | 39 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2014 | 21012 | 0.080 |
Why?
|
Umbilical Veins | 1 | 2010 | 426 | 0.080 |
Why?
|
Ataxia | 1 | 2011 | 306 | 0.080 |
Why?
|
Asthma | 2 | 1999 | 6234 | 0.080 |
Why?
|
Cleidocranial Dysplasia | 2 | 1999 | 18 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 732 | 0.080 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9420 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9177 | 0.080 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2008 | 53 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.080 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2011 | 372 | 0.080 |
Why?
|
Vaginal Smears | 2 | 2021 | 499 | 0.080 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2449 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1651 | 0.080 |
Why?
|
Inflammation | 6 | 2021 | 10773 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 4 | 2009 | 20570 | 0.080 |
Why?
|
Neurogenesis | 2 | 2012 | 863 | 0.080 |
Why?
|
Neoplasms | 2 | 2011 | 22170 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 632 | 0.070 |
Why?
|
Cohort Studies | 10 | 2020 | 41487 | 0.070 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2007 | 7 | 0.070 |
Why?
|
Technology, Radiologic | 1 | 2008 | 160 | 0.070 |
Why?
|
Progestins | 2 | 2006 | 301 | 0.070 |
Why?
|
Washington | 2 | 1999 | 315 | 0.070 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3617 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6484 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15842 | 0.070 |
Why?
|
Head | 2 | 2010 | 924 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4511 | 0.070 |
Why?
|
Methyl Green | 1 | 2006 | 6 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2872 | 0.070 |
Why?
|
Macrophages | 2 | 2020 | 5769 | 0.070 |
Why?
|
Diet, Reducing | 1 | 2010 | 485 | 0.070 |
Why?
|
Unsafe Sex | 1 | 2008 | 238 | 0.070 |
Why?
|
Aquaporin 4 | 1 | 2007 | 161 | 0.070 |
Why?
|
Retinopathy of Prematurity | 1 | 2011 | 439 | 0.070 |
Why?
|
Epithelial Cells | 4 | 2021 | 3673 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2942 | 0.070 |
Why?
|
Ferrets | 2 | 2018 | 177 | 0.070 |
Why?
|
Specimen Handling | 1 | 2011 | 702 | 0.070 |
Why?
|
Cerebral Ventricles | 1 | 2008 | 542 | 0.070 |
Why?
|
Professional Practice | 1 | 2008 | 313 | 0.070 |
Why?
|
Urinary Incontinence | 1 | 2010 | 489 | 0.070 |
Why?
|
Inclusion Bodies | 2 | 2023 | 281 | 0.070 |
Why?
|
Life Style | 1 | 2017 | 3917 | 0.060 |
Why?
|
Proteomics | 2 | 2020 | 3849 | 0.060 |
Why?
|
Cicatrix | 2 | 2023 | 798 | 0.060 |
Why?
|
Ovariectomy | 1 | 2008 | 614 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 1111 | 0.060 |
Why?
|
Twins | 1 | 2007 | 339 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 5368 | 0.060 |
Why?
|
Time Factors | 8 | 2016 | 39967 | 0.060 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6814 | 0.060 |
Why?
|
Gene Expression | 2 | 2023 | 7581 | 0.060 |
Why?
|
Microtubules | 1 | 2011 | 1074 | 0.060 |
Why?
|
Young Adult | 5 | 2023 | 59243 | 0.060 |
Why?
|
Radiology Department, Hospital | 1 | 2009 | 406 | 0.060 |
Why?
|
beta-Defensins | 1 | 2005 | 59 | 0.060 |
Why?
|
Mesothelioma, Cystic | 1 | 2004 | 4 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3826 | 0.060 |
Why?
|
Cell Movement | 4 | 2018 | 5203 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2021 | 1834 | 0.060 |
Why?
|
Hypotrichosis | 1 | 2024 | 7 | 0.060 |
Why?
|
Behavior Therapy | 1 | 2010 | 879 | 0.060 |
Why?
|
Enteric Nervous System | 1 | 2007 | 212 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3290 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2017 | 3612 | 0.060 |
Why?
|
Acanthosis Nigricans | 1 | 2004 | 47 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1422 | 0.060 |
Why?
|
Flavonoids | 1 | 2007 | 445 | 0.060 |
Why?
|
Sterilization, Tubal | 2 | 2016 | 75 | 0.060 |
Why?
|
Keratins | 2 | 2023 | 498 | 0.060 |
Why?
|
United States | 9 | 2021 | 72334 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7594 | 0.060 |
Why?
|
Anthropometry | 1 | 2009 | 1349 | 0.060 |
Why?
|
Prognosis | 7 | 2019 | 29625 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2022 | 12795 | 0.060 |
Why?
|
Carcinoma, Verrucous | 1 | 2004 | 27 | 0.060 |
Why?
|
Foot Deformities, Congenital | 1 | 2024 | 59 | 0.060 |
Why?
|
Coloring Agents | 1 | 2006 | 562 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 358 | 0.060 |
Why?
|
Mullerian Ducts | 1 | 2005 | 203 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5890 | 0.060 |
Why?
|
Odds Ratio | 2 | 2014 | 9646 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1897 | 0.060 |
Why?
|
DNA, Viral | 3 | 2010 | 2202 | 0.060 |
Why?
|
Health Care Costs | 1 | 1997 | 3242 | 0.060 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2003 | 23 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 244 | 0.060 |
Why?
|
Neurotransmitter Agents | 1 | 2007 | 665 | 0.060 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2003 | 50 | 0.060 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1667 | 0.060 |
Why?
|
Body Fluids | 2 | 2002 | 320 | 0.060 |
Why?
|
Gonadotropins | 1 | 2004 | 241 | 0.050 |
Why?
|
Heart | 2 | 2021 | 4404 | 0.050 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 162 | 0.050 |
Why?
|
Caffeine | 1 | 2008 | 700 | 0.050 |
Why?
|
Vertigo | 1 | 2005 | 202 | 0.050 |
Why?
|
Plasma Cells | 1 | 2006 | 599 | 0.050 |
Why?
|
Societies, Medical | 3 | 2021 | 3905 | 0.050 |
Why?
|
Infant | 7 | 2022 | 36192 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1509 | 0.050 |
Why?
|
Signal Transduction | 4 | 2016 | 23445 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3492 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2116 | 0.050 |
Why?
|
Macaca mulatta | 2 | 2020 | 2329 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2004 | 469 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4652 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2002 | 13380 | 0.050 |
Why?
|
Sexually Transmitted Diseases | 1 | 2008 | 662 | 0.050 |
Why?
|
Cell Differentiation | 5 | 2014 | 11528 | 0.050 |
Why?
|
Ovulation Induction | 1 | 2004 | 277 | 0.050 |
Why?
|
Cyclin E | 1 | 2022 | 156 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2005 | 439 | 0.050 |
Why?
|
Microtomy | 1 | 2002 | 44 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3802 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2011 | 1886 | 0.050 |
Why?
|
Sacrum | 1 | 2024 | 276 | 0.050 |
Why?
|
Genes, Wilms Tumor | 1 | 2002 | 92 | 0.050 |
Why?
|
DNA-Binding Proteins | 5 | 2013 | 9606 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2004 | 233 | 0.050 |
Why?
|
Neuropeptides | 1 | 2007 | 944 | 0.050 |
Why?
|
Neocortex | 1 | 2006 | 417 | 0.050 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2002 | 39 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2016 | 7856 | 0.050 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7390 | 0.050 |
Why?
|
Vulvar Neoplasms | 1 | 2004 | 263 | 0.050 |
Why?
|
Albumins | 1 | 2004 | 575 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2021 | 73 | 0.050 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 751 | 0.050 |
Why?
|
Complement Inactivating Agents | 1 | 2021 | 53 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2006 | 1076 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2024 | 853 | 0.050 |
Why?
|
Animals | 15 | 2020 | 168459 | 0.050 |
Why?
|
Cytomegalovirus Infections | 1 | 2007 | 831 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2822 | 0.050 |
Why?
|
Mutation | 6 | 2019 | 30052 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2018 | 2678 | 0.040 |
Why?
|
Child, Preschool | 7 | 2018 | 42230 | 0.040 |
Why?
|
Child | 8 | 2023 | 80153 | 0.040 |
Why?
|
Motivation | 1 | 2010 | 2006 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 128 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2002 | 1870 | 0.040 |
Why?
|
Homosexuality, Male | 1 | 2008 | 1334 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1303 | 0.040 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1263 | 0.040 |
Why?
|
Epithelium | 1 | 2005 | 1603 | 0.040 |
Why?
|
Jejunal Neoplasms | 1 | 2000 | 19 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2007 | 1351 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4920 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 710 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2002 | 326 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2014 | 10445 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2023 | 675 | 0.040 |
Why?
|
Adolescent | 6 | 2018 | 88319 | 0.040 |
Why?
|
Chromosome Deletion | 2 | 2006 | 1386 | 0.040 |
Why?
|
Algorithms | 3 | 2016 | 14031 | 0.040 |
Why?
|
Chondrosarcoma | 1 | 2002 | 296 | 0.040 |
Why?
|
Video Recording | 1 | 2005 | 966 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2019 | 40 | 0.040 |
Why?
|
Genes, myc | 1 | 2000 | 390 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 21353 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1117 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 295 | 0.040 |
Why?
|
Colonic Polyps | 1 | 2004 | 554 | 0.040 |
Why?
|
Larva | 1 | 2001 | 508 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3708 | 0.040 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2020 | 93 | 0.040 |
Why?
|
Colectomy | 1 | 2004 | 688 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3877 | 0.040 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 1999 | 112 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2010 | 4936 | 0.040 |
Why?
|
Weight Loss | 1 | 2010 | 2684 | 0.040 |
Why?
|
Breast Feeding | 1 | 2007 | 1359 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 718 | 0.040 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2001 | 237 | 0.040 |
Why?
|
Salts | 2 | 1995 | 63 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1999 | 420 | 0.040 |
Why?
|
Ubiquitin | 1 | 2023 | 839 | 0.040 |
Why?
|
Menopause | 2 | 2016 | 1646 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 652 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1092 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 386 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
Online Systems | 1 | 2019 | 182 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.040 |
Why?
|
Informed Consent | 1 | 2005 | 1008 | 0.040 |
Why?
|
Heparitin Sulfate | 1 | 1999 | 223 | 0.040 |
Why?
|
Haplotypes | 1 | 2024 | 2713 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1115 | 0.040 |
Why?
|
Peritoneal Neoplasms | 1 | 2004 | 711 | 0.040 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1999 | 251 | 0.040 |
Why?
|
Brain Injuries | 1 | 2010 | 2053 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3979 | 0.040 |
Why?
|
Multivariate Analysis | 5 | 2012 | 12059 | 0.040 |
Why?
|
Risk Assessment | 8 | 2013 | 23995 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2169 | 0.040 |
Why?
|
Viral Load | 2 | 2021 | 3332 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36426 | 0.040 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2001 | 339 | 0.040 |
Why?
|
Narcotics | 1 | 1999 | 336 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 583 | 0.040 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2013 | 517 | 0.040 |
Why?
|
DNA Primers | 2 | 2007 | 2819 | 0.040 |
Why?
|
Methadone | 1 | 1999 | 321 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3639 | 0.030 |
Why?
|
Platelet Activation | 1 | 2020 | 645 | 0.030 |
Why?
|
Oxidative Stress | 3 | 2016 | 3113 | 0.030 |
Why?
|
Mice, Transgenic | 4 | 2012 | 9539 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2011 | 16981 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2004 | 1292 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1078 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2002 | 1035 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1967 | 0.030 |
Why?
|
Leg | 1 | 2001 | 1088 | 0.030 |
Why?
|
Organizational Policy | 1 | 1998 | 432 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1606 | 0.030 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2016 | 35 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1085 | 0.030 |
Why?
|
Boston | 2 | 2009 | 9326 | 0.030 |
Why?
|
Proteoglycans | 1 | 1999 | 803 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 422 | 0.030 |
Why?
|
Mice | 10 | 2015 | 81525 | 0.030 |
Why?
|
Disease Progression | 3 | 2010 | 13506 | 0.030 |
Why?
|
Follow-Up Studies | 6 | 2012 | 39106 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 18965 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17635 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 783 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1089 | 0.030 |
Why?
|
Growth Plate | 1 | 2017 | 274 | 0.030 |
Why?
|
Base Sequence | 4 | 2007 | 12441 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4028 | 0.030 |
Why?
|
Viral Structural Proteins | 1 | 1995 | 95 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1995 | 329 | 0.030 |
Why?
|
Femur | 1 | 2001 | 1307 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1125 | 0.030 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1994 | 30 | 0.030 |
Why?
|
Patient Compliance | 2 | 2010 | 2690 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1242 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2006 | 418 | 0.030 |
Why?
|
Electrolytes | 1 | 1995 | 274 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2203 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.030 |
Why?
|
Regression Analysis | 2 | 2009 | 6343 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2113 | 0.030 |
Why?
|
Pedigree | 2 | 2018 | 4542 | 0.030 |
Why?
|
Cell Division | 2 | 2015 | 4465 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 2016 | 554 | 0.030 |
Why?
|
Cyclin B | 1 | 2014 | 104 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2208 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2639 | 0.030 |
Why?
|
Trophoblasts | 1 | 2015 | 224 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2015 | 1058 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2811 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 1998 | 1156 | 0.030 |
Why?
|
Genes, Viral | 1 | 1995 | 649 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1611 | 0.030 |
Why?
|
Menarche | 1 | 2016 | 532 | 0.030 |
Why?
|
Adenoma | 1 | 2004 | 2160 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3702 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 506 | 0.030 |
Why?
|
Nephrectomy | 1 | 2018 | 937 | 0.030 |
Why?
|
Fibronectins | 1 | 2017 | 723 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 461 | 0.030 |
Why?
|
HIV Protease | 1 | 2013 | 97 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2865 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1742 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2008 | 4330 | 0.030 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
Apoptosis | 3 | 2018 | 9486 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2011 | 1745 | 0.030 |
Why?
|
Lymphoma | 1 | 2002 | 1901 | 0.030 |
Why?
|
DNA | 2 | 1997 | 7212 | 0.030 |
Why?
|
Diet | 2 | 2007 | 8075 | 0.030 |
Why?
|
Cell Line | 3 | 2015 | 15601 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2015 | 547 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1511 | 0.020 |
Why?
|
Postnatal Care | 1 | 2014 | 262 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2004 | 1922 | 0.020 |
Why?
|
Hypertrophy | 1 | 2014 | 561 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2002 | 1157 | 0.020 |
Why?
|
Viral Regulatory and Accessory Proteins | 3 | 1998 | 153 | 0.020 |
Why?
|
Osteoblasts | 1 | 1997 | 1143 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2004 | 5112 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 983 | 0.020 |
Why?
|
Adenoviridae | 1 | 2015 | 1084 | 0.020 |
Why?
|
Ubiquitination | 1 | 2016 | 1006 | 0.020 |
Why?
|
Germany | 1 | 2013 | 875 | 0.020 |
Why?
|
Drug Utilization | 1 | 1997 | 1188 | 0.020 |
Why?
|
Menstruation Disturbances | 1 | 1992 | 143 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2013 | 629 | 0.020 |
Why?
|
Parvoviridae Infections | 1 | 2010 | 36 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7237 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4758 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2448 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2414 | 0.020 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2010 | 23 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2015 | 2180 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4141 | 0.020 |
Why?
|
Thermodynamics | 3 | 1998 | 595 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 319 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 3429 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 295 | 0.020 |
Why?
|
Age Factors | 3 | 2016 | 18395 | 0.020 |
Why?
|
Cystadenocarcinoma | 1 | 2009 | 54 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2016 | 1208 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2004 | 4026 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 407 | 0.020 |
Why?
|
Ureaplasma Infections | 1 | 2009 | 25 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 250 | 0.020 |
Why?
|
Twins, Dizygotic | 1 | 2010 | 236 | 0.020 |
Why?
|
Child Development | 2 | 2012 | 2306 | 0.020 |
Why?
|
Calcinosis | 1 | 2018 | 1469 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4278 | 0.020 |
Why?
|
Guideline Adherence | 1 | 1999 | 2220 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2001 | 2529 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2008 | 89 | 0.020 |
Why?
|
Fetofetal Transfusion | 1 | 2010 | 112 | 0.020 |
Why?
|
San Francisco | 1 | 2008 | 162 | 0.020 |
Why?
|
Cephalometry | 1 | 2010 | 382 | 0.020 |
Why?
|
Ligands | 1 | 1995 | 3272 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3548 | 0.020 |
Why?
|
Carboplatin | 1 | 2011 | 794 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 1999 | 158 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 12947 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2827 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1988 | 0.020 |
Why?
|
Inclusion Bodies, Viral | 1 | 2007 | 45 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2008 | 240 | 0.020 |
Why?
|
Abortion, Eugenic | 1 | 2007 | 39 | 0.020 |
Why?
|
Protein Binding | 2 | 2017 | 9351 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2011 | 617 | 0.020 |
Why?
|
Bone and Bones | 2 | 2014 | 2568 | 0.020 |
Why?
|
Inpatients | 1 | 1998 | 2548 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2020 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3734 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9318 | 0.020 |
Why?
|
Aborted Fetus | 1 | 2006 | 11 | 0.020 |
Why?
|
Heart Failure | 1 | 2010 | 11669 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1997 | 2775 | 0.020 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2006 | 127 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3395 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2932 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 1997 | 1923 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 64680 | 0.020 |
Why?
|
Kidney Tubules | 1 | 2007 | 449 | 0.020 |
Why?
|
Infant Mortality | 1 | 2010 | 759 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
Hospitalization | 2 | 1997 | 10723 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2008 | 569 | 0.010 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4740 | 0.010 |
Why?
|
Viral Proteins | 3 | 1998 | 1804 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1999 | 2164 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.010 |
Why?
|
Self Concept | 1 | 2010 | 1045 | 0.010 |
Why?
|
Fetal Organ Maturity | 1 | 2004 | 83 | 0.010 |
Why?
|
Bacteremia | 1 | 2011 | 979 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 4243 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2707 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3810 | 0.010 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2010 | 518 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5821 | 0.010 |
Why?
|
Metaplasia | 1 | 2005 | 322 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1999 | 3613 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1112 | 0.010 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 140 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5035 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 870 | 0.010 |
Why?
|
Coffee | 1 | 2008 | 593 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1134 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11903 | 0.010 |
Why?
|
Maternal Exposure | 1 | 2010 | 1067 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 940 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 2007 | 756 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4111 | 0.010 |
Why?
|
Apolipoproteins D | 1 | 2002 | 14 | 0.010 |
Why?
|
Models, Chemical | 2 | 1995 | 611 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2831 | 0.010 |
Why?
|
Prevalence | 2 | 2010 | 15732 | 0.010 |
Why?
|
Nasal Bone | 1 | 2002 | 57 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2008 | 3087 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 2002 | 189 | 0.010 |
Why?
|
Hernia, Inguinal | 1 | 2004 | 220 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4398 | 0.010 |
Why?
|
T-Box Domain Proteins | 1 | 2004 | 469 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1613 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 2002 | 106 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11118 | 0.010 |
Why?
|
Cell Death | 1 | 2006 | 1678 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2007 | 799 | 0.010 |
Why?
|
Embryo Transfer | 1 | 2004 | 522 | 0.010 |
Why?
|
Parents | 1 | 2014 | 3563 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2007 | 14414 | 0.010 |
Why?
|
Neuroglia | 1 | 2006 | 956 | 0.010 |
Why?
|
Proteins | 1 | 1995 | 6032 | 0.010 |
Why?
|
HIV Infections | 2 | 2008 | 17351 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 592 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 2002 | 247 | 0.010 |
Why?
|
Salivary Gland Neoplasms | 1 | 2004 | 304 | 0.010 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 1999 | 68 | 0.010 |
Why?
|
Nose Neoplasms | 1 | 2002 | 249 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5774 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2141 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4061 | 0.010 |
Why?
|
Syndrome | 1 | 2006 | 3267 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3778 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 1998 | 33 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2477 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2665 | 0.010 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1999 | 274 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2007 | 2909 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2004 | 974 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 1999 | 26125 | 0.010 |
Why?
|
Static Electricity | 1 | 1998 | 261 | 0.010 |
Why?
|
Rhode Island | 1 | 1998 | 351 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 2000 | 249 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1130 | 0.010 |
Why?
|
Risk | 1 | 2009 | 9610 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2010 | 3415 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 1991 | 0.010 |
Why?
|
Colonoscopy | 1 | 2004 | 1394 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1997 | 367 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5305 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2691 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1975 | 60 | 0.010 |
Why?
|
Intercalating Agents | 1 | 1995 | 33 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6228 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1232 | 0.010 |
Why?
|
Karyotyping | 1 | 1997 | 1171 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2004 | 3162 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5079 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6075 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1999 | 625 | 0.010 |
Why?
|
Bacteriophage lambda | 1 | 1994 | 142 | 0.010 |
Why?
|
Electrochemistry | 1 | 1994 | 145 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1994 | 168 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1998 | 2496 | 0.010 |
Why?
|
Computer Graphics | 1 | 1995 | 340 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1999 | 2078 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4575 | 0.010 |
Why?
|
Sterilization, Reproductive | 1 | 1992 | 24 | 0.010 |
Why?
|
Vasectomy | 1 | 1992 | 51 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2510 | 0.010 |
Why?
|
Mammography | 1 | 2002 | 2430 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1997 | 6132 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10090 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4615 | 0.000 |
Why?
|
Alleles | 1 | 1999 | 6863 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 2004 | 4320 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10766 | 0.000 |
Why?
|
Indoles | 1 | 1995 | 1833 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10194 | 0.000 |
Why?
|
Radiography | 1 | 1997 | 6965 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13446 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22169 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1999 | 12341 | 0.000 |
Why?
|
Length of Stay | 1 | 1998 | 6425 | 0.000 |
Why?
|
Aging | 1 | 2004 | 8708 | 0.000 |
Why?
|
Models, Molecular | 1 | 1994 | 5439 | 0.000 |
Why?
|
Genotype | 1 | 1997 | 12990 | 0.000 |
Why?
|
Models, Biological | 1 | 1998 | 9469 | 0.000 |
Why?
|